JAC's EPMA Wins Technology Innovation Award

JAC have been presented with the 2009 European e-Prescription Systems Technology Innovation Award by Frost & Sullivan (F&S). The award was based on research by F&S's own analysts and recognises JAC for continuously innovating and upgrading individual disciplines of e-prescription technology.

The award citation reads: "The company's innovative technology, coupled with uncompromising customer support, contribute to JAC's success in medicines management and makes their EPMA the most trusted e-prescribing solution among the United Kingdom's (UK) hospitals. JAC's technology provides clinicians with a solution that can manage the entire medicines therapy data in one system; assuring care provider organisations that the therapy documentation is done accurately, the appropriate safety checks are carried out and the results can be reviewed in real time. With over 25 years of expertise, JAC's medicines management technologies are in phase with the changing healthcare environment."

On being presented with the award, Robert Tysall-Blay, JAC's CEO, commented: "It is very gratifying that the work done over the years in conjunction with our clients has led to the recognition it deserves. We gratefully accept this award on behalf of all our staff and valued customers."

There was even more cause for celebration on the night as Intersystems, JAC's key technology partner, received the European Hospital Information System Customer Value Leadership Award for demonstrating high levels of customer satisfaction and increasing customer loyalty and retention through its enhanced product offering and customer service.

InterSystems has topped recent industry surveys on cost effectiveness, vendor executive involvement, job performance improvement, product quality rating and on-time implementation within budget.

Philip Birchall, InterSystems' Healthcare Business Development Director, added: "InterSystems is delighted to receive this Award, as it recognises our commitment to providing market-leading, connected healthcare software supported by a life-long partnership with our healthcare customers to help them meet the continually evolving challenges of this unique marketplace."

Related news articles:

About Frost & Sullivan
Frost & Sullivan's mission is to research and analyze new market opportunities for corporate growth. They are the world leader in growth consulting and the integrated areas of technology research, market research, economic research, corporate best practices, training, customer research, competitive intelligence and corporate strategy.

www.frost.com

About JAC Computer Services
JAC Computer Services Ltd (JAC) is the leading supplier of medicines management solutions to the NHS as well as to key sites in Ireland and South Africa. JAC's UK user-base now accounts for around half of all NHS trusts in England as well as sites in Scotland, Wales and Northern Ireland.

JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated solution along with associated services. JAC is also the exclusive distributor in the UK and Ireland of ServeRx ward-based automation technologies for medicines and medical equipment.

The JAC solution for E-Prescribing and Medicines Administration (EPMA) includes integrated in-patient, out-patient and discharge prescribing with decision support for clinical checking on allergies, drug-drug interactions and therapeutic duplicates. In addition EPMA supports medicines administration recording and can be used at the patient's bedside by doctors, nurses and other clinicians.

In June 1996, JAC was acquired by Mediware Information Systems, a global provider of clinical software systems for healthcare. Mediware is publicly traded on the NASDAQ exchange in the United States (NASDAQ: MEDW) and has more than 1400 institutions worldwide using its blood and medicines management software products.

www.jac-pharmacy.co.uk

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...